1. Field of Invention
The present invention relates to plasma processing and more particularly to reducing contamination of a diagnostic system used in plasma processing.
2. Description of Background Information
Typically, plasma is a collection of species, some of which are gaseous and some of which are charged. Plasmas are useful in certain processing systems for a wide variety of applications. For example, plasma processing systems are of considerable use in material processing and in the manufacture and processing of semiconductors, integrated circuits, displays and other electronic devices, both for etching and layer deposition on substrates, such as, for example, semiconductor wafers.
Diagnostic methods are widely used to monitor plasma processes and associated substrates and to determine an end point of a plasma process, for example, a plasma etching process. Diagnostic methods can include optical diagnostic methods or pressure measurement methods, for example. Maintenance is required when the diagnostic sensor becomes contaminated with plasma by-products.
One aspect of the invention is to provide a plasma processing system in communication with a diagnostic system. The plasma processing system comprises a chamber containing a plasma processing region, a chuck constructed and arranged to support a substrate within the chamber in the processing region and a chamber opening formed in a wall of the chamber to enable plasma within the plasma processing region to exit the chamber. A plasma generator is positioned in communication with the chamber and is constructed and arranged to generate a plasma during a plasma process in the plasma processing region. The diagnostic system includes a passageway formed between the plasma processing region and a diagnostic sensor. The passageway has a predetermined length and a predetermined diameter. The passageway is configured to have a length to diameter ratio, which is provided by dividing the predetermined length of the passageway by the predetermined diameter of the passageway, of at least 4.
Another aspect of the invention is to provide a method for operating a diagnostic system in communication with a plasma processing system. The plasma processing system has a chamber containing a plasma processing region in which a plasma can be generated during a plasma process and the diagnostic system. The diagnostic system monitors the plasma processing region and/or a substrate in the chamber. The method comprises providing a passageway formed between the plasma processing chamber and the diagnostic sensor with the passageway having a length to diameter ratio of at least 4. The method further comprises detecting an emission from the plasma processing region and/or substrate through an opening in the chamber and reducing contamination of the diagnostic system. Thus, a method can be provided to reduce contamination of a diagnostic system, e.g., an optical diagnostic assembly or a diagnostic assembly.
In embodiments of the invention, the diagnostic system includes a contamination reducing structure which is configured to reduce contamination of the passageway associated with the diagnostic sensor. In one embodiment, the contamination reducing structure can include a gas purge passageway configured to introduce a purge gas into the passageway. In other embodiments, the contamination reducing structure can include an electric field generator, a magnetic field generator, a temperature controlled system, or a combination of at least two of an electric field generator, a magnetic field generator, a temperature controlled system and a gas purge passageway to reduce contamination of the passageway associated with the diagnostic sensor.
The accompanying drawings, which are incorporated in and constitute a part of the specification, of embodiments of the invention, together with the general description given above and the detailed description of the embodiments given below, serve to explain the principles of the invention wherein:
The plasma processing system 10 comprises a plasma process chamber, generally indicated at 14, that defines a plasma processing region 16 in which a plasma 18 can be generated. A chuck or electrode 30 can be positioned in the chamber 14 and is constructed and arranged to support a substrate 20, which can be a semiconductor wafer, for example, within the chamber 14 in the processing region 16. The substrate 20 can be a semiconductor wafer, integrated circuit, a sheet of a polymer material to be coated, a metal to be surface hardened by ion implantation, or some other semiconductor material to be etched or deposited, for example.
Although not shown, coolant can be supplied to the chuck 30, for example, through cooling supply passages coupled to the chamber 14. Each cooling supply passage can be coupled to a cooling supply source. For example, the cooling supply passages can be individually connected to the cooling supply source. Alternatively, cooling supply passages can be interconnected by a network of interconnecting passages, which connect all cooling supply passages in some pattern.
Generally, plasma generation gas, which can be any gas that is ionizable to produce a plasma, is introduced into the chamber 14 to be made into a plasma, for example, through a gas inlet 26. The plasma generation gas can be selected according to the desired application as understood by one skilled in the art and can be nitrogen, xenon, argon, carbon tetrafluoride (CF4) or octafluorocyclobutane (C4F8) for fluorocarbon chemistries, chlorine (Cl2), hydrogen bromide (HBr), or oxygen (O2), for example.
The gas inlet 26 is coupled to the chamber 14 and is configured to introduce plasma processing gases into the plasma processing region 16. A plasma generator in the form of upper electrode 28 and lower electrode 30 can be coupled to the chamber 14 to generate the plasma 18 within the plasma processing region 16 by ionizing the plasma processing gases. The plasma processing gases can be ionized by supplying RF and/or DC power thereto, for example. In some applications, the plasma generator can be an antenna or RF coil capable of supplying RF power, for example.
A variety of gas inlets or injectors and various gas injecting operations can be used to introduce plasma processing gases into the plasma processing chamber 14, which can be hermetically sealed and can be formed from aluminum or another suitable material. The plasma processing gases are often introduced from gas injectors or inlets located adjacent to or opposite from the substrate. For example, as shown in
Alternatively, in embodiments not shown, the gases can be injected through a dielectric window opposite the substrate in a transformer coupled plasma (TCP) source. Other gas injector arrangements are known to those skilled in the art and can be employed in conjunction with the plasma processing chamber 14.
The plasma processing chamber 14 is fitted with an outlet having a first vacuum pump 32 and a valve 34, such as a throttle control valve, to provide gas pressure control in the plasma process chamber 14.
Various leads (not shown), for example, voltage probes or other sensors, can be coupled to the plasma processing system 10.
An opening 22 extends radially from the process chamber 14 through a chamber wall 36 to the diagnostic system 12. Generally, in diagnostic assemblies having pressure sensors or mass spectrometers, the opening 22 can be made large to allow faster sensor response. In optical diagnostic assemblies, the opening 22 can be made large to allow a stronger signal or signals to be transmitted to and collected by the optical diagnostic assembly or detector.
The diagnostic system 12 is generally vacuum tight and can be formed in communication with the process chamber 14 to enable communication with the plasma processing region 16, as will be described in further detail below.
A gate valve (not shown) can be coupled to the plasma process chamber 14, adjacent to the chamber opening 22 and between the plasma process chamber 14 and the diagnostic system 12. The gate valve can be provided to allow isolation of the diagnostic system 12 from the plasma processing chamber 14 for maintenance operations, such as calibrating or recalibrating sensors in a diagnostic assembly, cleaning a window in an optical diagnostic assembly, replacing the window in an optical diagnostic assembly or periods of gas purge, for example. The gate valve is not essential to the invention and is omitted from the embodiment shown in
As shown in
As shown in
A flow restrictor element 50 can be mounted within the mounting walls 44 of the diagnostic system 12, by adhesive, bonding material or other suitable fasteners, to determine the amount of light or gas that reaches the diagnostic sensor 40 (e.g., by restricting the flow through the opening 22 formed in the chamber wall 36). The restrictor element 50 extends between the diagnostic sensor 40 and the plasma processing region 16. The diameter of the passageway 46 is effectively determined by the size of the restrictor element 50. The restrictor element 50 can be integrally formed with the mounting portion 38. That is, rather than having a separate restrictor element, the inner wall of mounting portion 38 inherently defines a restrictor.
The flow restrictor element 50, the mounting portion 38 or both the flow restrictor element 50 and the mounting portion 38 can be made from metals, e.g., aluminum, anodized aluminum and stainless steel, dielectric materials, e.g., ceramics such as quartz, alumina, silicon-carbide and silicon-nitride, semiconductor materials, e.g., silicon, doped silicon and other materials. For example, in plasma processes involving aggressive chemistries, such as fluorine-based chemistries, a flow restrictor element made from semiconductor materials, e.g., silicon, can reduce the concentration of aggressive species.
The mounting walls 44 can also optionally include a gas purge passageway 54 coupled thereto for communication with a pre-chamber area 52, formed between the restrictor element 50 and the diagnostic sensor 40. The gas purge passageway 54 can be integrally formed with the mounting walls 44, as shown in
The gas purge passageway 54 allows a purge gas to be provided to the pre-chamber area 52, for example (as indicated by an arrow labeled B in
In plasma processes that do not involve aggressive chemistry, the gas purge passageway 56 and the flow restrictor element 50 may be eliminated from the diagnostic system 12. This is because contamination of the diagnostic system 12, e.g., the passageway 46 or the diagnostic sensor 40, is greater in processes that involve aggressive chemistry, and with non-aggressive chemistry there is no need to restrict the flow or use purge gas.
A spectrometer (not shown) can be incorporated in the diagnostic sensor 40 to detect a plasma process condition based on an optical emission, e.g., light, from the plasma 18, or may be separate from the sensor 40. The spectrometer or the detector system can be associated with a photomultiplier tube, a CCD or other solid state detector to at least partially detect the plasma process condition, such as an endpoint of a plasma process, for example. However, other optical devices capable of analyzing an optical emission or properties of a wafer, e.g., films associated with the wafer, can be used as well.
A controller 56 capable of generating control voltages sufficient to communicate and activate inputs to plasma processing system 10 as well as capable of monitoring outputs from the plasma processing system 10 can be coupled to the plasma processing system 14. For example, the controller 56 can be coupled to and can exchange information with the upper electrode 28, the lower electrode 30 and the gas inlet 26. A program, which can be stored in a memory, can be utilized to control the aforementioned components of plasma processing system 10 according to a stored process recipe. Furthermore, controller 56 is capable of controlling the components of the diagnostic system 12. For example, the controller 56 can be configured to control the diagnostic sensor 40. Alternatively, multiple controllers 56 can be provided, each of which being configured to control different components of either the plasma processing system 10 or the diagnostic system 12, for example. One example of the controller 56 is an embeddable PC computer type PC/104 from Micro/SYS of Glendale, Calif.
The diagnostic system 112 includes a mounting portion 138, which can be made from the same materials as the mounting portion 38 described above. The mounting portion 138 has a mounting flange 142 (or a plurality of the same) with fasteners (not shown) to couple the mounting flange 142 to the chamber wall 36. A plurality of mounting walls 144a, 144b, which can have a tubular or cylindrical configuration, can extend from the mounting flange 142. The mounting walls 144a, 144b form a fluid chamber 143 therebetween. The fluid chamber 143 can have a tubular or cylindrical configuration and can be in communication with a fluid inlet 158, which is coupled to the outer mounting wall 144b. The fluid inlet 158 is configured to carry fluid, e.g., gas or liquid, to the fluid chamber 143. A fluid outlet 160 is coupled to the mounting wall 144b in communication with an opposite end of the fluid chamber 143 from the fluid inlet 158. The fluid inlet 158 or the fluid outlet 160 can be integral with the wall portion 144b or can be fastened to the wall portion 144b on opposite sides of the passageway 46 with suitable fasteners. The fluid inlet 158 and the fluid outlet 160 can be positioned anywhere along the mounting wall 144b. For example, the fluid inlet 158 can be provided adjacent the gas purge passageway 54 and the fluid outlet 160 can be provided on the opposite side of the passageway 46 or vice versa.
Depending on the plasma process application, a temperature of the fluid introduced into the fluid chamber 143 can be selected, e.g., an elevated temperature (e.g., 250° C.) or a reduced temperature (e.g., −196° C.), with respect to a gas temperature inside of the pre-chamber area 52 and the passageway 46. An elevated temperature can generally reduce film contamination in some plasma chemistries, while a reduced temperature, e.g., cryogenic, can cause rapid adsorption of contaminants in the plasma in the passageway 46 so that contaminants do not reach the diagnostic sensor 40. Thus, the fluid temperature can be controlled and selected to help reduce contamination of the diagnostic sensor 40.
To provide elevated temperatures, the wall portion 144b and the chamber 143 can be replaced with a heater, e.g., an electric heater, wrapped around an outer periphery of the wall portion 144a. Alternatively, the heater could be implemented in combination with the wall portion 144b and the fluid chamber 143.
The diagnostic system 212 includes a mounting portion 238, which can be made from the same materials as the mounting portion 38 described above. The mounting portion 238 has a mounting flange 242 (or a plurality of the same) with fasteners (not shown) to couple the mounting flange 242 to the chamber wall 36. A mounting wall 244, which can have a tubular or cylindrical configuration, can extend from the mounting flange 242. The mounting wall 244 is configured to receive an insulator 262, such as silica (quartz), alumina or another dielectric material, and an electric field generator 264 mounted thereto, e.g., by fasteners, adhesive, bonding material or other suitable fasteners. The insulator 262 insulates an outer portion of the electric field generator 264.
The mounting wall 244 can have an opening 266 formed therein for receiving a feedthrough element 268. The feedthrough element 268 couples the electric field generator 264, which can include an annular electrode or a plurality of electrodes, with a power supply 270. The power supply 270 can supply either DC or radio frequency (RF) bias power to the electric field generator 264.
Depending on the plasma process application, either DC or RF biased power can be used to repel plasma from the passageway 46. For example, a strong negative DC bias at moderate to high pressures, e.g., pressures equal to or greater than about 40 mTorr, can substantially reduce plasma in the processing chamber 14 from entering the pre-chamber 52 and the passageway 46 or vicinities thereof by repelling electrons in the plasma from the passageway 46. Other electrodes can be used to provide the DC or RF power such that the electrode can be biased to the same charge of the plasma charged species to repel those species (e.g., a positive electrode can be used to repel ions in the plasma). In other words, a “standing-off” effect is provided, in which the plasma is confined to an area outside the passageway 46 or a vicinity thereof. At the moderate to high pressures, ions in the plasma can frequently collide with other particles in the plasma to further reduce plasma light-up within the passageway 46 or a vicinity thereof.
The diagnostic system 312 includes a mounting portion 338, which can be made from the same materials as the mounting portion 38 described above. The mounting portion 338 has a mounting flange 342 (or a plurality of the same) with fasteners (not shown) to couple the mounting flange 342 to the chamber wall 36. A mounting wall 344, which can have a tubular or cylindrical configuration, can extend from the mounting flange 342. The mounting wall 344 has an opening 372 formed therein, which is configured to receive a magnetic field generator 376 and a magnetic field leakage reducing member 374 therein. The magnetic field generator 376, which can include one or more permanent magnets or current-carrying coils, is configured to produce a magnetic field (generally indicated at 378 in
The magnetic field leakage reducing member 374 can be an iron ring, for example, or any other structure capable of reducing leakage of the magnetic field outside the passageway 46. Thus, the possibility of the magnetic field 378 affecting the plasma process within the plasma processing chamber 14, and the diagnostic system 40, can be reduced.
Depending on the plasma process application, the magnetic field generator 376 can be configured to form the magnetic field 378 across the passageway such that plasma is substantially prevented from entering the pre-chamber 52 and the passageway 46 or vicinities thereof. In other words, the magnetic field 378 can shield plasma generally outside (within the plasma processing chamber 14) the passageway 46.
The configuration of magnets 380 shown in
The diagnostic system 412 includes a mounting portion 438, which can be made from the same materials as the mounting portion 38 described above. The mounting portion 438 has the mounting flange 342 (or a plurality of the same) and the mounting wall 344 described above. The magnetic field generator 476 can be mounted within the opening 372 by appropriate mounting elements.
The configuration of magnets 480 shown in
The magnetic field 478 is less strong than the magnetic field 378 described above because the field strength at the center of the passageway 46 is zero. However, with its lesser strength, the magnetic field 478 can be used in plasma processes in which strong magnetic fields induce undesirable effects, which can affect measurement, e.g., providing a pumping effect on the plasma that affects pressure measurements.
With respect to
In the above embodiments, shown in
A diagnostic sensor, which is not shown for simplicity, can be operatively associated with the diagnostic system 512. The diagnostic sensor can operate in substantially the same manner as the sensor 40 shown in
The mounting wall 544 has an interior surface 545 that defines a passageway 546 having a predetermined diameter D. The diameter D of the passageway 546 can be equal to, smaller or larger than the diameter of the opening 22 formed in the chamber wall 36.
The passageway 546 has a predetermined length L, which can be defined in this embodiment as the distance from the chamber opening 22 to the diagnostic sensor element 539 or to the diagnostic sensor. The length L can be selected to be longer than the gas mean free path of molecules of a contaminant at the selected process conditions, e.g., processing chamber pressure, chamber gas flow and chamber gas temperature. Because the length L of the passageway 546 is selected to be X times longer than the gas mean free path of contaminant molecules at the selected process conditions, a contaminant molecule will generally experience X number of collisions on its way through the passageway 546. Thus, the number of contaminant molecules that reach the diagnostic sensor or the diagnostic sensing element 539 is reduced, at least partially due to the X number of collisions. In this conceptual example, X may represent a number greater than zero, e.g., 25, 55, 85 or higher. However, X can be selected to be any number depending on the gas mean free path of contaminant molecules and the selected process conditions, which can vary depending on the plasma process.
The length L and the diameter D of the passageway 546 can be selected to provide a length to diameter ratio (L/D) of at least 4, which can be obtained by dividing the length L of the passageway by the diameter D of the passageway 546. The passageway 546 can be configured to provide length to diameter ratios greater than 4 depending on the plasma process being used or process characteristics, e.g., processing chamber pressure, chemistry, gas flow, and temperature, thereof.
The gas purge passageway 556 operates in substantially the same manner as the gas purge passageway 56 described above with respect to
The diameter D of the passageway 646 can be equal to, smaller or larger than the diameter of the opening 22 formed in the chamber wall 36.
The length L and the diameter D of the passageway 646 are selected to provide a length to diameter ratio (L/D) of at least 4, which can be obtained by dividing the length L of the passageway by the diameter D of the passageway 646. The passageway 646 can be configured to provide length to diameter ratios greater than 4 depending on the plasma process being used process characteristics, e.g., processing chamber pressure, chamber gas flow and chamber gas temperature, thereof. The gas purge passageway 646 helps further reduce contamination of the diagnostic sensing element 539 (and in turn the diagnostic sensor).
The flow restrictor element 550, which may be made from the same materials as the flow restrictor element 50 described above, extends along the interior surface 545 of the mounting wall 544 from the chamber opening 22 to the diagnostic sensor element 539 or to the diagnostic sensor. The flow restrictor element 550 has an interior surface 555 that defines a passageway 746 having a predetermined diameter D. The diameter D of the passageway 746 can be equal to, smaller or larger than the diameter of the opening 22 formed in the chamber wall 36. As illustrated, the diameter D of the passageway 746 is smaller than the opening 22.
The passageway 746 has a predetermined length L, which can be defined in this embodiment as the distance from the chamber opening 22 to the diagnostic sensor element 539 or to the diagnostic sensor. As discussed above, the length L of the passageway 746 can be selected to be longer than the gas mean free path of contaminant molecules at the selected process conditions.
The length L and the diameter D of the passageway 746 are selected to provide a length to diameter ratio (L/D) of at least 4, which can be obtained by dividing the length L of the passageway by the diameter D of the passageway 746. The passageway 746 can be configured to provide length to diameter ratios greater than 4 depending on the plasma process being used or process characteristics, e.g., processing chamber pressure, chamber gas flow and chamber gas temperature, thereof.
The diagnostic system 812 provides another way to implement a flow restrictor element into a diagnostic system. Specifically, in the diagnostic system 812, an end portion 639 of the flow restrictor element 650 is configured to abut a recessed portion 637 formed in the chamber wall 636.
The flow restrictor element 650, which may be made from the same materials as the flow restrictor element 50 described above, extends from the recessed portion 637, which is adjacent to the chamber opening 22, to the diagnostic sensor element 539 or to the diagnostic sensor. The flow restrictor element 650 defines a passageway 846 having a predetermined diameter D. The diameter D of the passageway 846 can be equal to, smaller or larger than the diameter of the opening 22 formed in the chamber wall 36. As illustrated, the diameter D of the passageway 846 is smaller than the opening 22.
The passageway 846 has a predetermined length L, which can be defined in this embodiment as the distance from the end portion 637 of the flow restrictor element 650 to the diagnostic sensor element 539 or to the diagnostic sensor. As discussed above, the length L of the passageway 846 can be selected to be longer than the gas mean free path of contaminant molecules at the selected process conditions.
The length L and the diameter D of the passageway 846 are selected to provide a length to diameter ratio (L/D) of at least 4, which can be obtained by dividing the length L of the passageway by the diameter D of the passageway 846. The passageway 846 can be configured to provide length to diameter ratios greater than 4 depending on the plasma process being used or process characteristics, e.g., processing chamber pressure, chamber gas flow and chamber gas temperature, thereof.
The diagnostic system 912 includes a mounting portion 738, which can be made from the same materials as the mounting portion 38 described above. The mounting portion 738 has the tapered mounting wall 744 coupled to the chamber wall 36 by one or more fasteners 537. The fastener(s) may be one or more of a seal, an O-ring or any other type of sealing fastener capable of coupling the mounting wall 744 to the chamber wall 36.
The flow restrictor element 750, which may be made from the same materials as the flow restrictor element 50 described above, extends along the interior surface 745 of the mounting wall 744 from the chamber opening 22 to the diagnostic sensor element 539 or to the diagnostic sensor. The flow restrictor element 750 has a tapered outer surface 755, which abuts the opening in the chamber wall 36 to help support the flow restrictor element 750 within the chamber wall 36. The flow restrictor element 750 defines a passageway 946 having a predetermined diameter D. The diameter D of the passageway 946 can be equal to, smaller or larger than the diameter of the opening 22 formed in the chamber wall 36.
As illustrated, the diameter D of the passageway 946 is smaller than the opening 22 and is constant along the length L thereof. However, the passageway 946 can have a variable diameter configured to increase or decrease along the passageway 946. For example, the diameter D of the passageway 946 can incrementally increase in a direction toward the diagnostic sensor element 539 or to the diagnostic sensor, as shown in
The passageway 946 has a predetermined length L, which can be defined in this embodiment as the distance from the chamber opening 22 to the diagnostic sensor element 539 or to the diagnostic sensor. As discussed above, the length L of the passageway 946 can be selected to be longer than the gas mean free path of contaminant molecules at the selected process conditions.
The length L and the diameter D of the passageway 946 are selected to provide a length to diameter ratio (L/D) of at least 4, which can be obtained by dividing the length L of the passageway by the diameter D of the passageway 946. The passageway 946 can be configured to provide length to diameter ratios greater than 4 depending on the plasma process being used or process characteristics, e.g., processing chamber pressure, chamber gas flow and chamber gas temperature, thereof. In passageways having a variable diameter D, an average diameter along a length L thereof can be used to provide the length to diameter ratio (L/D) of at least 4.
Although a passageway having a variable diameter D is only described in relation to the passageway 946, other passageways, e.g., passageways 46, 546, 646, 746 and 846, described herein can also be configured to have a variable diameter, e.g., increasing or decreasing along a length of the passageway.
The method starts at 1300. At 1302, contamination of a diagnostic sensor is substantially reduced. The backflow of contaminants from the plasma processing chamber through the passageway (and a pre-chamber area, if provided) to the diagnostic sensor associated with the plasma processing system can be substantially reduced. For example, the plasma is substantially shielded from entering the passageway (and a pre-chamber area, if provided) formed in the diagnostic system between the diagnostic system and the plasma processing chamber or vicinities thereof. A purge gas can be introduced into the pre-chamber area for substantially shielding the plasma from entering the passageway and the pre-chamber area. The method can comprise acts, operations or procedures, such as, for example, providing a heating element, a cooling element, an electric field, or a magnetic field, in combination or separately, to reduce contamination of the pre-chamber and passageway connecting the pre-chamber and the plasma processing chamber. Various combinations of these additional acts, operations or procedures could be used as well. For example, a diagnostic system could employ a magnetic field and an electric field, in combination with or separate from, the purge gas to shield plasma from entering the pre-chamber and the passageway.
At 1304, a condition of the plasma process is detected by a diagnostic system capable of receiving the condition, e.g., light, gas or pressure, from the plasma processing region and/or the substrate. For example, a plasma processing condition, such as an endpoint of the plasma process, can be detected using the diagnostic system. At 1306, the method ends.
One such method to detect a plasma process condition through an optical window is disclosed in U.S. Application of Mitrovic et al., Attorney Docket 291738, filed concurrently herewith, the contents of which are incorporated by reference herein in their entirety.
While the present invention has been particularly shown and described with reference to the preferred embodiments thereof, it will be understood by those skilled in the art that various changes in form and details can be made therein without departing from the spirit and scope of the invention.
For example, the system 12 can be used with substantially all diagnostic systems with only slight modifications for the introduction of laser beams for diagnostic purposes or materials processing, into a processing chamber. The system 12 can be associated with one or more RF probes or antennas configured to monitor harmonic content of the plasma. For example, one or more RF probes can be mounted outside the plasma processing chamber 14, e.g., to replace or in conjunction with the diagnostic sensor 40, to monitor RF energy from the plasma processing chamber 14 and analyze harmonic content thereof.
Thus, the foregoing embodiments have been shown and described for the purpose of illustrating the functional and structural principles of this invention and are subject to change without departure from such principles. Therefore, this invention includes all modifications encompassed within the spirit and scope of the following claims.
This is a continuation of International Application No. PCT/US03/30051, filed Sep. 25, 2003, which relies for priority upon U.S. Provisional Application No. 60/414,349, filed on Sep. 30, 2002, the entire contents of both of which are incorporated herein by reference in their entireties. This continuation of PCT application is also related to International Application No. PCT/US03/26208, filed Aug. 21, 2003, which relies to priority on U.S. Provisional Patent Application No. 60/414,348, filed Sep. 30, 2003, the entire contents of both of which are incorporated herein by reference.
Number | Date | Country | |
---|---|---|---|
60414349 | Sep 2002 | US |
Number | Date | Country | |
---|---|---|---|
Parent | PCT/US03/30051 | Sep 2003 | US |
Child | 11082246 | Mar 2005 | US |